Product Recalls in Wisconsin

Product recalls affecting Wisconsin — including food, drugs, consumer products, medical devices, and vehicles distributed to Wisconsin. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,720 recalls have been distributed to Wisconsin in the last 12 months.

52,482 total recalls
2,720 in last 12 months

Showing 38413860 of 52,482 recalls

DrugNovember 19, 2024· Rising Pharma Holding, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules USP Recalled by Rising Pharma Holding,...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Rising Pharma Holding, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules USP Recalled by Rising Pharma Holding,...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
Medical DeviceNovember 19, 2024· Greiner Bio-One GmbH

Recalled Item: VACUETTE SAFELINK Recalled by Greiner Bio-One GmbH Due to The VACUETTE...

The Issue: The VACUETTE SAFELINK Holder with male luer lock may leak blood due to the...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
Medical DeviceNovember 19, 2024· Baxter Healthcare Corporation

Recalled Item: Baxter SIGMA Spectrum Infusion Pump with Master Drug Library (Version 8)...

The Issue: Devices were identified as released after repair without full testing being...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
Medical DeviceNovember 19, 2024· Baxter Healthcare Corporation

Recalled Item: Baxter SIGMA Spectrum Infusion Pump with Master Drug Library (Version 6)...

The Issue: Devices were identified as released after repair without full testing being...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
Medical DeviceNovember 19, 2024· Olympus Corporation of the Americas

Recalled Item: Duravent Silicone Ventilation Tube. Model Number: 240075. Recalled by...

The Issue: Potential that Duravent Silicone Ventilation Tubes may contain incorrect...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
DrugNovember 18, 2024· Endo USA, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablets Recalled by Endo USA, Inc. Due to...

The Issue: Labeling: Label Error on Declared Strength; Some cartons were incorrectly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 18, 2024· Endo USA, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablets Recalled by Endo USA, Inc. Due to...

The Issue: Labeling: Label Error on Declared Strength; Some cartons were incorrectly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 18, 2024· Endo USA, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablet Recalled by Endo USA, Inc. Due to...

The Issue: Labeling: Label Error on Declared Strength; Some cartons were incorrectly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 18, 2024· Endo USA, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablets Recalled by Endo USA, Inc. Due to...

The Issue: Labeling: Label Error on Declared Strength; Some cartons were incorrectly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund